| |
| Issue |
Title |
| |
| Vol 15, No 5 (2023) |
Vestibular migraine: issues of diagnosis and optimization of therapy |
Abstract
PDF (Rus)
|
|
O. V. Zaitseva, T. G. Baskova, A. L. Latsinova, O. E. Wenger |
| |
| Vol 15, No 5 (2023) |
Comparative analysis of the use of selective serotonin reuptake inhibitors during pregnancy and the postpartum period. Safety of sertraline |
Abstract
PDF (Rus)
|
|
E. A. Ushkalova, A. V. Ushkalova |
| |
| Vol 15, No 5 (2023) |
Migraine in perimenopausal women |
Abstract
PDF (Rus)
|
|
D. A. Klimentova, G. R. Tabeeva |
| |
| Vol 15, No 5 (2023) |
Problems in the selection of effective analgesics for migraine |
Abstract
PDF (Rus)
|
|
G. R. Tabeeva |
| |
| Vol 15, No 5 (2023) |
Possibilities of combined use of peptides in the treatment of post-stroke asthenia |
Abstract
PDF (Rus)
|
|
A. Yu. Emelin, V. Yu. Lobzin |
| |
| Vol 15, No 5 (2023) |
Depressive disorders and their pharmacotherapy in routine clinical practice |
Abstract
PDF (Rus)
|
|
S. N. Mosolov, V. A. Parfenov, A. V. Amelin, V. E. Medvedev, V. D. Mendelevich, G. M. Usov, Yu. P. Sivolap, A. N. Bogolepova, E. A. Mkhitaryan, D. S. Petelin |
| |
| Vol 15, No 5 (2023) |
The phenomenon of “visual snow”: clinical and pathophysiological correlations, differential diagnosis and treatment (literature review) |
Abstract
PDF (Rus)
PDF (Eng)
|
|
A. S. Kamaeva, E. A. Kiryanova, G. R. Tabeeva |
| |
| Vol 15, No 5 (2023) |
The role of cellular immunity and systemic inflammation indices in the pathogenetic mechanisms of mental disorders |
Abstract
PDF (Rus)
|
|
A. P. Gorbunova, G. V. Rukavishnikov, E. D. Kasyanov, G. E. Mazo |
| |
| Vol 15, No 5 (2023) |
Diagnosis and treatment of depression according to the functional recovery paradigm |
Abstract
PDF (Rus)
|
|
G. M. Usov |
| |
| Vol 15 (2023): (Suppl. 1) |
Prolonged observation after the use of cladribine in multiple sclerosis: efficacy and safety |
Abstract
PDF (Rus)
|
|
A. D. Kukushkina, A. N. Boyko |
| |
| Vol 15 (2023): (Suppl. 1) |
Neuromyelitis optic spectrum disorders (NMOSD): from pathogenesis to targeted therapy |
Abstract
PDF (Rus)
|
|
P. A. Zaitseva, A. N. Boyko |
| |
| Vol 15 (2023): (Suppl. 1) |
The evolution of interferon therapy in multiple sclerosis |
Abstract
PDF (Rus)
|
|
O. V. Boyko, N. F. Smirnova, A. N. Boyko |
| |
| Vol 15 (2023): (Suppl. 1) |
Prospects for the use of curcumin as an additional treatment for multiple sclerosis |
Abstract
PDF (Rus)
|
|
V. S. Rogovskii, A. D. Kukushkina, A. N. Boyko |
| |
| Vol 15 (2023): (Suppl. 1) |
Diagnostic criteria and treatment of neuromyelitis optica spectrum disorders (NMOSD) |
Abstract
PDF (Rus)
|
|
T. O. Simaniv, K. Z. Bakhtiyarova, A. N. Belova, Z. A. Goncharova, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, T. N. Trushnikova, E. L. Turova, T. I. Khaibullin, M. A. Sherman, A. N. Boyko |
| |
| Vol 15, No 4 (2023) |
Endocrine-inactive pituitary tumors: pathology and current approaches to diagnosis and treatment |
Abstract
PDF (Rus)
|
|
V. N. Nikolenko, B. A. Volel, A. N. Shkarubo, A. A. Nagajtseva, T. S. Zharikova, Yu. O. Zharikov |
| |
| Vol 15, No 4 (2023) |
Paramagnetic rim sign in multiple sclerosis |
Abstract
PDF (Rus)
|
|
D. V. Kapkanets, S. E. Belov, M. B. Dolgushin, A. N. Boyko |
| |
| Vol 15, No 4 (2023) |
The role of trimethylamine-N-oxide in the development of cerebrovascular disease (brief review) |
Abstract
PDF (Rus)
|
|
M. A. Kutlubaev, A. R. Rakhmatullin, R. F. Kutlubaeva |
| |
| Vol 15, No 4 (2023) |
Pharmaconutraceutical Chondroguard®TRIO – chondroprotector with immunomodulatory activity |
Abstract
PDF (Rus)
|
|
O. A. Shavlovskaya, Yu. D. Yukhnovskaya, I. D. Romanov, I. A. Bokova |
| |
| Vol 15, No 3 (2023) |
Efficacy and safety of a daytime anxiolytic containing technologically processed antibodies to the S100 protein. Overview of clinical studies |
Abstract
PDF (Rus)
PDF (Eng)
|
|
M. Perez, N. N. Zavadenko, L. A. Skipetrova, I. I. Smirnov, Yu. E. Nesterovskiy |
| |
| Vol 15, No 3 (2023) |
Issues of management of patients with post-stroke cognitive impairment |
Abstract
PDF (Rus)
|
|
A. B. Lokshina, D. A. Grishina |
| |
| Vol 15, No 3 (2023) |
Vitamin B12 deficiency and Parkinson’s disease |
Abstract
PDF (Rus)
|
|
Z. A. Zalyalova, E. V. Ekusheva |
| |
| Vol 15, No 3 (2023) |
Parkinson’s disease. Focus on early stages |
Abstract
PDF (Rus)
|
|
E. A. Katunina, Z. A. Zalyalova, D. V. Pokhabov, M. Z. Ivanova, A. M. Semenova |
| |
| Vol 15, No 2 (2023) |
Cognitive disorders in amyotrophic lateral sclerosis |
Abstract
PDF (Rus)
|
|
M. A. Kutlubaev, D. K. Areprintceva, E. V. Pervushina, L. V. Brylev |
| |
| Vol 15, No 2 (2023) |
Headache and epilepsy: prevalence and clinical variants |
Abstract
PDF (Rus)
PDF (Eng)
|
|
V. V. Osipova, A. R. Artemenko, D. A. Shmidt, E. A. Antipenko |
| |
| Vol 15, No 2 (2023) |
Depression in patients with cerebral microangiopathy |
Abstract
PDF (Rus)
|
|
A. N. Bogolepova |
| |
| Vol 15, No 2 (2023) |
Management of patients with chronic cerebrovascular disease |
Abstract
PDF (Rus)
|
|
Yu. A. Starchina, O. V. Kosivtsova, E. A. Sokolov |
| |
| Vol 15, No 2 (2023) |
Diagnosis and therapy of obsessive-compulsive spectrum disorders in general medical and neurological practice |
Abstract
PDF (Rus)
|
|
D. S. Petelin, A. N. Gamirova, O. Yu. Sorokina, D. V. Troshina, S. A. Semin, M. Sh. Boltueva, B. A. Volel |
| |
| Vol 15, No 2 (2023) |
Vascular cognitive impairment: issues of diagnosis and treatment |
Abstract
PDF (Rus)
|
|
A. B. Lokshina, D. A. Grishina, V. V. Zakharov |
| |
| Vol 15, No 2 (2023) |
Efficacy and safety of aceclofenac in musculoskeletal diseases |
Abstract
PDF (Rus)
|
|
M. A. Isaikina, A. I. Isaikin, L. T. Akhmedzhanova |
| |
| Vol 15, No 2 (2023) |
Antioxidant therapy in the complex treatment of patients with ischemic stroke in the acute and recovery period |
Abstract
PDF (Rus)
|
|
Yu. A. Belova, S. V. Kotov |
| |
| Vol 15, No 1 (2023) |
Modern aspects of diagnosis and treatment of cognitive impairments (literature review) |
Abstract
PDF (Rus)
|
|
A. B. Lokshina, V. V. Zakharov, N. V. Vakhnina |
| |
| Vol 15, No 1 (2023) |
The gut microbiome as a factor in the development of Parkinson's disease |
Abstract
PDF (Rus)
|
|
L. A. Brsikyan, E. A. Poluektova, M. G. Poluektov |
| |
| Vol 15, No 1 (2023) |
Management of patients with cognitive impairment |
Abstract
PDF (Rus)
|
|
V. A. Parfenov |
| |
| Vol 15, No 1 (2023) |
Meniere's disease in the practice of a neurologist |
Abstract
PDF (Rus)
|
|
O. V. Kosivtsova, Y. A. Starchina |
| |
| Vol 14, No 6 (2022) |
Mild cognitive impairment treatment issues |
Abstract
PDF (Rus)
|
|
L. A. Shсhepankevich, I. A. Gribacheva, T. F. Popova, E. V. Taneeva, K. V. Roerich, E. V. Petrova, M. S. Shchepankevich |
| |
| Vol 14, No 6 (2022) |
Issues of improving the management of patients with ischemic stroke on the background of atrial fibrillation |
Abstract
PDF (Rus)
|
|
A. A. Kulesh, D. A. Demin |
| |
| Vol 14, No 6 (2022) |
On the use of chondroitin sulfate, glucosamine sulfate and undenatured type II collagen for back and limb pain and osteoarthritis |
Abstract
PDF (Rus)
|
|
O. A. Gromova, I. Y. Torshin, A. M. Lila |
| |
| Vol 14, No 6 (2022) |
Brain commissures and related pathologies |
Abstract
PDF (Rus)
|
|
V. N. Nikolenko, N. A. Rizaeva, M. V. Oganesyan, K. A. Vekhova, N. A. F. Alyautdinova, S. I. Balan, T. A. Karashaeva, A. A. Bolotskaya |
| |
| Vol 14, No 6 (2022) |
Drug-induced non-traumatic intracranial hemorrhage associated with the use of anticoagulants and antiplatelet agents |
Abstract
PDF (Rus)
|
|
O. D. Ostroumova, A. I. Listratov, T. M. Ostroumova, A. I. Kochetkov, D. A. Sychev |
| |
| Vol 14, No 6 (2022) |
Alzheimer's disease and COVID-19 |
Abstract
PDF (Rus)
|
|
N. N. Koberskaya, F. A. Roshchin |
| |
| Vol 14, No 6 (2022) |
Treatment of acute non-specific back pain, the use of group B vitamins |
Abstract
PDF (Rus)
|
|
V. A. Parfenov |
| |
| Vol 14, No 6 (2022) |
Recombinant botulinum toxin as a new stage in the development of botulinum toxin therapy. Possibilities and perspectives of use in neurological practice |
Abstract
PDF (Rus)
|
|
R. K. Shikhkerimov, E. V. Istomina |
| |
| Vol 14, No 5 (2022) |
Emotional disorders and their therapy in chronic low back pain |
Abstract
PDF (Rus)
|
|
A. I. Isaikin, T. I. Nasonova, A. Kh. Mukhametzyanova |
| |
| Vol 14, No 5 (2022) |
Apathy, anhedonia and cognitive dysfunction: common symptoms of depression and neurological disorders |
Abstract
PDF (Rus)
PDF (Eng)
|
|
D. S. Petelin, S. P. Bairamova, O. Yu. Sorokina, I. N. Niinoja, A. B. Lokshina, B. A. Volel |
| |
| Vol 14, No 5 (2022) |
Cervical radiculopathy |
Abstract
PDF (Rus)
PDF (Eng)
|
|
A. I. Isaikin, T. E. Schmidt, Yu. M. Shor |
| |
| Vol 14, No 5 (2022) |
Current view on the diagnosis and treatment of neuromyelitis optica spectrum disorders exacerbations |
Abstract
PDF (Rus)
|
|
V. S. Krasnov, L. N. Prakhova, N. A. Totolyan |
| |
| Vol 14, No 5 (2022) |
Safety of Mexidol® (ethylmethylhydroxypyridine succinate) in adult patients of different age groups |
Abstract
PDF (Rus)
|
|
E. A. Ushkalova, S. K. Zyryanov, O. I. Butranova |
| |
| Vol 14, No 5 (2022) |
Dysphagia in Alzheimer's disease |
Abstract
PDF (Rus)
|
|
N. N. Koberskaya |
| |
| Vol 14, No 4 (2022) |
Pharmacotherapy of pain in musculoskeletal diseases: evolution and revolution of views |
Abstract
PDF (Rus)
|
|
O. A. Shavlovskaya, I. V. Sarvilina, O. A. Gromova, M. N. Sharov, I. A. Bokova, Y. S. Prokofieva, N. I. Shavlovskiy |
| |
| Vol 14, No 4 (2022) |
Cognitive impairment in patients with coronavirus infection |
Abstract
PDF (Rus)
|
|
Y. A. Starchina, O. V. Kosivtsova |
| |
| Vol 14, No 4 (2022) |
Piribedil in the treatment of mental and cognitive impairments in Parkinson's disease |
Abstract
PDF (Rus)
|
|
E. V. Yakovenko, F. A. Abbasov |
| |
| Vol 14, No 4 (2022) |
Clinical features of mental disorders during the pandemic of a new coronavirus infection |
Abstract
PDF (Rus)
|
|
N. A. Tyuvina, V. O. Vysokova, E. N. Efremova, O. V. Lavrinenko |
| |
| Vol 14, No 4 (2022) |
Adherence to antidepressant therapy: clinical experience on the example of agomelatine |
Abstract
PDF (Rus)
|
|
N. N. Petrova |
| |
| Vol 14, No 4 (2022) |
The role of oxidative stress in the development of Alzheimer's disease |
Abstract
PDF (Rus)
|
|
V. N. Nikolenko, N. A. Rizaeva, K. V. Bulygin, V. M. Anokhina, A. A. Bolotskaya |
| |
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз |
Free circulating miRNA as a potential diagnostic marker in multiple sclerosis (review) |
Abstract
PDF (Rus)
|
|
M. A. Omarova, M. S. Kozin, A. N. Boyko |
| |
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз |
Ways to improve adherence to long-term injection therapy in multiple sclerosis using the example of pegylated interferon-β1a (sampeginterferon β-1a) |
Abstract
PDF (Rus)
|
|
A. N. Boyko |
| |
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз |
Review of human interferons and the potential of their use in the complex therapy of a new coronavirus infection COVID-19 |
Abstract
PDF (Rus)
|
|
E. V. Granatov, A. R. Abashev, F. A. Khabirov, A. Ya. Dykhanov, T. I. Khaibullin |
| |
| Vol 14, No 3 (2022) |
Approaches to psychotherapy for chronic musculoskeletal pain |
Abstract
PDF (Rus)
PDF (Eng)
|
|
D. S. Petelin, N. S. Istomina, D. S. Tsapko, A. A. Magomedov, V. E. Bezrukov, M. S. Kochergina, A. N. Gamirova, B. A. Volel |
| |
| Vol 14, No 3 (2022) |
Combined therapy for Alzheimer's disease |
Abstract
PDF (Rus)
|
|
V. V. Zakharov, A. V. Lokshina, N. V. Vakhnina |
| |
| Vol 14, No 3 (2022) |
Possibilities of antiplatelet therapy in non-cardioembolic ischemic stroke |
Abstract
PDF (Rus)
|
|
M. Yu. Maksimova, A. S. Airapetova |
| |
| Vol 14, No 3 (2022) |
Cognitive and emotional disorders in patients with chronic heart failure: prospects for detection and correction |
Abstract
PDF (Rus)
|
|
V. N. Shishkova |
| |
| Vol 14, No 3 (2022) |
Anticoagulant therapy as a part of secondary stroke prevention in patients with atrial fibrillation |
Abstract
PDF (Rus)
|
|
O. D. Ostroumova, T. M. Ostroumova |
| |
| Vol 14, No 2 (2022) |
Treatment of mental disorders of generative cycle in women |
Abstract
PDF (Rus)
|
|
V. E. Medvedev |
| |
| Vol 14, No 2 (2022) |
Post-COVID pain syndrome: a review of international observations |
Abstract
PDF (Rus)
|
|
O. A. Shavlovskaya, I. A. Bokova, N. I. Shavlovskiy |
| |
| Vol 14, No 2 (2022) |
Muscular factor in the development of musculoskeletal pain. Treatment options |
Abstract
PDF (Rus)
|
|
A. I. Isaikin, T. I. Nasonova |
| |
| Vol 14, No 1 (2022) |
Hormone therapy for menstrual-associated migraine: pros and cons |
Abstract
PDF (Rus)
|
|
E. A. Kiryanova, G. R. Тabeeva |
| |
| Vol 14, No 1 (2022) |
Biological basis of aggressive behavior |
Abstract
PDF (Rus)
|
|
O. A. Makushkina, O. I. Gurina, V. A. Golenkova |
| |
| Vol 14, No 1 (2022) |
Impact of different classes of antidepressants on sleep and wakefulness regulation in depression |
Abstract
PDF (Rus)
|
|
G. M. Usov, D. Yu. Kolomytsev, L. M. Lomiashvili |
| |
| Vol 14, No 1 (2022) |
Kinesiotherapy and non-steroidal anti-inflammatory drugs for nonspecific lumbago |
Abstract
PDF (Rus)
|
|
A. A. Golovacheva, V. A. Golovacheva, V. A. Parfenov |
| |
| Vol 13, No 6 (2021) |
Migraine in children and adolescents: modern principles of diagnostics and treatment |
Abstract
PDF (Rus)
|
|
V. A. Golovacheva, A. A. Golovacheva, L. M. Antonenko |
| |
| 1 - 70 of 353 Items |
1 2 3 4 5 6 > >>
|
